Roy D. Baynes - Director at Travere Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
TVTX on Nasdaq
All Insider Reports
All Insider Reports

Roy D. Baynes - trading volume in the past year for Travere Therapeutics, Inc.

Holdings reported by Roy D. Baynes for Travere Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 37,500 $687,375 $18.33 15 May 2025 Direct
Stock option (right to buy) 19,500 15 May 2025 Direct Common Stock

Transactions reported by Roy D. Baynes for Travere Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.